Ambalal Sarabhai Enterprises' Stock Reaches All-Time High, Outperforms Sector and Sensex

Jul 11 2024 09:20 AM IST
share
Share Via
Ambalal Sarabhai Enterprises, a microcap pharmaceutical company, has been making headlines in the stock market with its recent performance. Its stock price reached an all-time high on July 11, 2024, and has been consistently trading above its moving averages. With a 1-year performance of 153.69%, the company is gaining attention from investors for its potential in the pharma industry.

Ambalal Sarabhai Enterprises, a microcap pharmaceutical company, has been making waves in the stock market with its recent performance. On July 11, 2024, the company's stock price reached an all-time high, making it a hot topic among investors.

According to MarketsMOJO, a leading stock analysis platform, Ambalal Sarabhai Enterprises' stock is currently a "Buy" call. It has also been identified as part of the "Hidden Turnaround" on MarketsMOJO since July 8, 2024.

The company's stock has been on a winning streak for the past three days, with a consecutive gain of 34.27% during this period. Today, the stock opened with a gain of 3.31% and touched an intraday high of Rs 73, which is also its new 52-week high. This performance has outperformed the sector by 2.89%.

One notable aspect of Ambalal Sarabhai Enterprises' stock is that it has been consistently trading above its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a strong upward trend in the company's stock price.

In comparison to the Sensex, Ambalal Sarabhai Enterprises has shown an impressive 1-year performance of 153.69%, while the Sensex has only grown by 22.09%. This further highlights the company's strong performance and potential for growth.

As a microcap pharmaceutical company, Ambalal Sarabhai Enterprises has been gaining attention from investors due to its recent success in the stock market. With its consistent upward trend and strong performance, the company is definitely one to watch out for in the pharma industry.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News